Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Finished Goods (2016)

Rockwell Medical's Finished Goods history spans 6 years, with the latest figure at $3.0 million for Q3 2016.

  • For Q3 2016, Finished Goods rose 41.85% year-over-year to $3.0 million; the TTM value through Sep 2016 reached $3.0 million, up 41.85%, while the annual FY2015 figure was $2.2 million, 44.24% up from the prior year.
  • Finished Goods reached $3.0 million in Q3 2016 per RMTI's latest filing, up from $2.8 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $3.0 million in Q3 2016 to a low of $1.4 million in Q2 2014.
  • Average Finished Goods over 5 years is $1.8 million, with a median of $1.5 million recorded in 2014.
  • Peak YoY movement for Finished Goods: fell 8.83% in 2014, then surged 77.77% in 2016.
  • A 5-year view of Finished Goods shows it stood at $1.5 million in 2012, then decreased by 3.37% to $1.4 million in 2013, then increased by 8.83% to $1.5 million in 2014, then skyrocketed by 44.24% to $2.2 million in 2015, then surged by 36.02% to $3.0 million in 2016.
  • Per Business Quant, the three most recent readings for RMTI's Finished Goods are $3.0 million (Q3 2016), $2.8 million (Q2 2016), and $2.3 million (Q1 2016).